Guidance

Asthma long-acting ß2 agonists: use and safety

Uses of long-acting ß2 agonists and current safety advice.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 18 December 2014

Documents

Asthma Long-acting ß2 agonists: use and safety

HTML

Details

This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance for healthcare professionals covers:

• treatment
• safety
• available medicines
• advice for use in children

Published 18 December 2014